VCNX

Vaccinex Inc
0.5955
-0.0059 (-0.98%)

Vaccinex Inc. (VCNX) Fundamentals

Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb. The firm generates revenue from collaborative research, license, development and commercialization agreements.
SHARE INFORMATION
Market Cap$ 29,998,350
Shares Outstanding49,880,861
Float30,205,893
Percent Float60.56%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 900,000
Latest Fiscal EPS$ -0.79
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions45
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months172,851
Institutional Holdings Percent13.7%
Institutional Sold Previous 3 Months95,134
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months5,556,413
Insider Holdings Percent0.7
Insider Sold Previous 3 Months-
Insider Shares Owned344,994
TRADING INFO
52 Week High$ 2.28
52 Week Low$ 0.41
52 Week High Change$ -34.27
21 Day Moving Average$ 0.6183
21 Day Extended Moving Average$ 0.614977
50 Day Moving Average$ 0.6139
50 Day Extended Moving Average$ 0.624303
200 Day Moving Average$ 0.87194
200 Day Extended Moving Average$ 0.881449
10 Day Average Volume59,150
20 Day Average Volume49,780
30 Day Average Volume47,373
50 Day Average Volume59,603
Alpha-0.025275
Beta1.0745
Standard Deviation0.255895
R20.056795
7 Day Price Change$ 0.008
7 Day Percent Change1.35%
21 Day Price Change$ -0.0386
21 Day Percent Change-6.03%
30 Day Price Change$ 0.0014
30 Day Percent Change0.23%
Month to Date Price Change$ -0.0431
Month to Date Percent Change-6.69%
Quarter to Date Price Change$ -0.0431
Quarter to Date Percent Change-6.69%
180 Day Price Change$ -0.4186
180 Day Percent Change-41.04%
200 Day Price Change$ -0.5586
200 Day Percent Change-48.16%
Year to Date Price Change$ -0.0431
Year to Date Percent Change-6.69%

Vaccinex Inc. (VCNX) Key Ratios

PROFITABILITY
EBIT Margin-38,764.0%
EBITDA Margin-38,358.0%
Pre-Tax Profit Margin-29,283.4%
Profit Margin Count0.0%
Gross Margin100.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 50,000
Revenue Per Share$ 0.001
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.80
Total Debt To Equity0.10
Int Coverage1,384.40
Current Ratio4.00
Leverage Ratio1.20
Quick Ratio3.60
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ 23,356,349
Price to Sales599.967
Price to Free Cash-2.10
PE High Last 5 Years0.00
Price To Book4.80
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.90
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-162.75
Return on Equity-212.74
Return on Capital-192.64

Vaccinex Inc. (VCNX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte & Touche LLP
CEOMaurice Zauderer
Emplyoees41
Last AuditUE
CIK0001205922
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1895 Mount Hope Avenue
Rochester, NY 14620
Websitehttps://www.vaccinex.com
Facsimile+1 585 271-2765
Telephone+1 585 271-2700
Emailinfo@vaccinex.com


Your Recent History
NASDAQ
VCNX
Vaccinex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.